Alcohol Misuse, Gut Microbial Dysbiosis and PrEP Care Continuum: Application and Efficacy of SBIRT Intervention
Recruiting now · Not applicable
Conditions studied: Alcohol Use Disorder, Risk Behavior, Health, Dysbiosis, HIV Infections
In brief
This randomized control trial study among Pre-exposure prophylactic users (PrEP) aims to learn and determine the efficacy of Screening, brief intervention, and referral to treatment (SBRIT) in reducing the risk of alcohol use. The main questions it aims to answer are: 1. How alcohol use impacts the PrEP continuum and to understand how early intervention and treatment approach affects alcohol use and PrEP adherence. 2. Investigate the effectiveness of the SBIRT intervention in preventing hazardous alcohol use and its impact on gut dysbiosis in PrEP users. 3. To determine alterations in the gut microbiome (dysbiosis), intestinal homeostasis, systemic inflammation, and markers of liver disease associated with hazardous alcohol use among PrEP users.
Key facts
- Study ID
- NCT06005298
- Run by
- Shirish S Barve
- People needed
- 120
- Starts
- 2023-08-01
- Expected to finish
- 2027-10-24
- Last updated by the study team
- 2024-07-22
Who can join
Age: 18 and older, up to 85. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Age: 18-85 years
- Confirmation of seronegative HIV, Hep B, and Hep C status
- PrEP users
- English-speaking or Spanish speaking
- Cognitively competent to provide consent
- Attend a participating healthcare facility
You may not qualify if…
- Inability to consent
- Existing diagnosis of major psychiatric illness
- Unstable medical conditions (e.g., cancer)
- Taking immunosuppressants or Chemotherapy
- Taking daily antibiotics or probiotics
- Severe gastrointestinal/liver disease
- Autoimmune disease
Where it is running
- University of Louisville — Louisville, Kentucky, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.